Get our free email newsletter

St. Jude Medical Device Recall Gets FDA Class 1 Status

The U.S. Food and Drug Administration (FDA) has reclassified as a Class 1 Advisory a recent recall of high voltage defibrillator leads.

Announced in November 2015, the original recall involved St. Jude Medical’s Optisure-brand dual coil defibrillation leads. An unexpected variation in the manufacturing process reportedly resulted in a compromise of the lead insulation, with the potential for an electrical malfunction of the device. The company notified physicians who implanted the Optisure leads in patients, and has not received any reports of lead malfunction or patient injury related to the defect.

Class 1 recalls are reserved for those situations in which there is a reasonable probability that the use of a device could cause serious adverse health consequences or death.

- Partner Content -

A Dash of Maxwell’s: A Maxwell’s Equations Primer – Part One

Solving Maxwell’s Equations for real-life situations, like predicting the RF emissions from a cell tower, requires more mathematical horsepower than any individual mind can muster. These equations don’t give the scientist or engineer just insight, they are literally the answer to everything RF.

Read the complete text of the recall notice regarding defibrillation leads.

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, trending engineering news, and weekly recall alerts.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, trending engineering news, and weekly recall alerts.